Target
Lutropin-choriogonadotropic hormone receptor
Ligand
BDBM50230121
Substrate
n/a
Meas. Tech.
ChEMBL_100017 (CHEMBL709254)
Ki
2.2±n/a nM
Citation
 Haviy, FFitzpatrick, TDNichols, CJSwenson, REBush, ENDiaz, GNguyen, ANellans, HNHoffman, DJGhanbari, H Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokinetics. J Med Chem 35:3890-4 (1992) [PubMed]  Article 
Target
Name:
Lutropin-choriogonadotropic hormone receptor
Synonyms:
LH/CG-R | LSH-R | LSHR_RAT | Lhcgr | Luteinizing hormone receptor | Luteinizing hormone/Choriogonadotropin receptor | Lutropin-choriogonadotropic hormone receptor
Type:
PROTEIN
Mol. Mass.:
78049.26
Organism:
Rattus norvegicus
Description:
ChEMBL_97289
Residue:
700
Sequence:
MGRRVPALRQLLVLAVLLLKPSQLQSRELSGSRCPEPCDCAPDGALRCPGPRAGLARLSLTYLPVKVIPSQAFRGLNEVVKIEISQSDSLERIEANAFDNLLNLSELLIQNTKNLLYIEPGAFTNLPRLKYLSICNTGIRTLPDVTKISSSEFNFILEICDNLHITTIPGNAFQGMNNESVTLKLYGNGFEEVQSHAFNGTTLISLELKENIYLEKMHSGAFQGATGPSILDISSTKLQALPSHGLESIQTLIALSSYSLKTLPSKEKFTSLLVATLTYPSHCCAFRNLPKKEQNFSFSIFENFSKQCESTVRKADNETLYSAIFEENELSGWDYDYGFCSPKTLQCAPEPDAFNPCEDIMGYAFLRVLIWLINILAIFGNLTVLFVLLTSRYKLTVPRFLMCNLSFADFCMGLYLLLIASVDSQTKGQYYNHAIDWQTGSGCGAAGFFTVFASELSVYTLTVITLERWHTITYAVQLDQKLRLRHAIPIMLGGWLFSTLIATMPLVGISNYMKVSICLPMDVESTLSQVYILSILILNVVAFVVICACYIRIYFAVQNPELTAPNKDTKIAKKMAILIFTDFTCMAPISFFAISAAFKVPLITVTNSKILLVLFYPVNSCANPFLYAIFTKAFQRDFLLLLSRFGCCKRRAELYRRKEFSAYTSNCKNGFPGASKPSQATLKLSTVHCQQPIPPRALTH
  
Inhibitor
Name:
BDBM50230121
Synonyms:
CHEMBL217405
Type:
Small organic molecule
Emp. Form.:
C62H86N14O12
Mol. Mass.:
1219.4328
SMILES:
CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N1 |wU:39.49,57.71,31.36,23.28,5.4,82.86,wD:51.55,71.83,12.20,(27.09,-8.95,;27.46,-10.44,;28.95,-10.86,;30.04,-11.96,;31.53,-11.6,;29.6,-13.45,;30.55,-14.67,;29.69,-15.94,;28.21,-15.52,;28.15,-13.97,;26.88,-13.11,;26.98,-11.58,;25.49,-13.78,;25.37,-15.33,;26.65,-16.2,;26.55,-17.73,;27.83,-18.59,;27.71,-20.12,;29,-21,;26.33,-20.8,;24.21,-12.92,;22.82,-13.6,;22.72,-15.13,;21.54,-12.73,;21.65,-11.2,;23.04,-10.52,;24.32,-11.38,;23.14,-8.97,;20.15,-13.41,;18.89,-12.55,;18.99,-11.01,;17.49,-13.23,;17.38,-14.76,;18.15,-16.1,;17.36,-17.42,;19.68,-16.11,;16.21,-12.36,;14.83,-13.03,;14.71,-14.57,;13.55,-12.17,;13.66,-10.62,;15.04,-9.95,;15.15,-8.42,;16.54,-7.74,;17.82,-8.6,;19.2,-7.93,;17.71,-10.14,;16.31,-10.81,;12.16,-12.85,;10.88,-11.97,;10.99,-10.44,;9.49,-12.64,;9.38,-14.19,;10.67,-15.06,;8.21,-11.79,;6.83,-12.46,;6.71,-14.01,;5.54,-11.6,;5.65,-10.07,;7.05,-9.39,;8.58,-9.18,;8.85,-7.67,;7.49,-6.93,;7.12,-5.44,;5.63,-5,;4.53,-6.07,;4.89,-7.56,;6.37,-8,;4.17,-12.27,;2.88,-11.41,;3,-9.87,;1.49,-12.09,;1.38,-13.62,;2.14,-14.94,;3.65,-14.94,;4.41,-16.27,;3.65,-17.59,;2.12,-17.58,;1.37,-16.26,;.22,-11.23,;-1.18,-11.9,;-1.28,-13.43,;-2.34,-11.11,;-2.34,-9.69,;-3.87,-9.45,;-4.55,-10.83,;-6.06,-11.09,;-3.45,-11.92,)|
Structure:
Search PDB for entries with ligand similarity: